Use access key #2 to skip to page content.
$41.47 -0.06 (-0.14%)
11/21/2008 10:02 AM

Gilead Sciences, Inc. (GILD)

CAPS Rating:
****

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

View All Commentary (GILD)

Recs

0

Avatar drstocks1 (73.56) Submitted: 12/31/07 2:15 PM : Outperform Start Price: $46.27 GILD Score: 38.51

As a Doc I can onfirm that they are leader in HIV treatment, but more importantly Tenovir an HIV drug will be approved for Hepatiitis B usage. Current data indicate that it will be the most effective anti Hepatitis B drug on the market with no reported resistance.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links